TFS Capital’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-3,142
| Closed | -$86K | – | 292 |
|
|
2017
Q2 | $86K | Sell |
3,142
-714
| -19% | -$19.5K | 0.03% | 563 |
|
|
2017
Q1 | $128K | Sell |
3,856
-5,631
| -59% | -$187K | 0.04% | 560 |
|
|
2016
Q4 | $226K | Buy |
+9,487
| New | +$226K | 0.06% | 482 |
|
|
2016
Q3 | – | Sell |
-23,176
| Closed | -$517K | – | 939 |
|
|
2016
Q2 | $517K | Sell |
23,176
-63,344
| -73% | -$1.41M | 0.1% | 364 |
|
|
2016
Q1 | $1.8M | Sell |
86,520
-38,609
| -31% | -$803K | 0.26% | 94 |
|
|
2015
Q4 | $3.79M | Sell |
125,129
-27,819
| -18% | -$843K | 0.41% | 49 |
|
|
2015
Q3 | $3.78M | Sell |
152,948
-21,792
| -12% | -$538K | 0.36% | 56 |
|
|
2015
Q2 | $5.61M | Buy |
174,740
+141,825
| +431% | +$4.55M | 0.55% | 16 |
|
|
2015
Q1 | $1.18M | Buy |
32,915
+12,398
| +60% | +$443K | 0.12% | 292 |
|
|
2014
Q4 | $466K | Sell |
20,517
-76,343
| -79% | -$1.73M | 0.04% | 599 |
|
|
2014
Q3 | $1.88M | Buy |
96,860
+22,911
| +31% | +$444K | 0.16% | 191 |
|
|
2014
Q2 | $2.68M | Buy |
73,949
+37,393
| +102% | +$1.36M | 0.21% | 126 |
|
|
2014
Q1 | $1.42M | Sell |
36,556
-11,700
| -24% | -$454K | 0.09% | 332 |
|
|
2013
Q4 | $1.38M | Sell |
48,256
-9,893
| -17% | -$282K | 0.06% | 446 |
|
|
2013
Q3 | $2.08M | Buy |
58,149
+10,775
| +23% | +$386K | 0.09% | 304 |
|
|
2013
Q2 | $1.58M | Buy |
+47,374
| New | +$1.58M | 0.07% | 430 |
|